In addition, the immunological hypothesis that may explain the DM and LTBI relationship is based on glycation of the CD271 domain of mesenchymal stem cells in uncontrolled DM patients, which may change their lifespan, becoming a potential niche for MTB in LTBI (5, 39). This evidence concerns the gene NGFR and diabetes mellitus.